Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility

Covid-19 (SARS CoV-2) has become a deadly, world-wide pandemic. Although most who are infected survive, complications from the virus can be pronounced and long-lasting. To date, of all the respiratory viruses including influenza and coronaviruses, only influenza has had a drug (i.e., Tamiflu) specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallicano, G. Ian, Casey, John L., Fu, Jiayu, Mahapatra, Samiksha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659899/
https://www.ncbi.nlm.nih.gov/pubmed/33184504
http://dx.doi.org/10.1038/s41434-020-00210-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659899/
https://www.ncbi.nlm.nih.gov/pubmed/33184504
http://dx.doi.org/10.1038/s41434-020-00210-0

Ejemplares similares